Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...
Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.
A novel lentiviral packaging system enables production from a single-plasmid transfection instead of the standard four-plasmid process.
Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback